ALTIMMUNE, INC. Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation
ALTIMMUNE, INC. (ALT) reported Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation of $18.35 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-13.
Discontinued › Notes › Compensation Related Costs
us-gaap:AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation · last filed 2018-11-13
- ALTIMMUNE, INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2018-09-30 was $0.00.
- ALTIMMUNE, INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2018-06-30 was $0.00.
- ALTIMMUNE, INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2018-03-31 was $18.35K.
| Period end | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 3 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 6 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 9 month |
|---|---|---|---|
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $0.00 derived: sum of 2 quarters · filed 2018-11-13 | $18.35K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $18.35K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $18.35K 10-Q · filed 2018-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |